Bannaga, A.; Metzger, J.; Voigtländer, T.; Pejchinovski, M.; Frantzi, M.; Book, T.; James, S.; Gopalakrishnan, K.; Mischak, H.; Manns, M.P.;
et al. Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma. Cancers 2021, 13, 3786.
https://doi.org/10.3390/cancers13153786
AMA Style
Bannaga A, Metzger J, Voigtländer T, Pejchinovski M, Frantzi M, Book T, James S, Gopalakrishnan K, Mischak H, Manns MP,
et al. Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma. Cancers. 2021; 13(15):3786.
https://doi.org/10.3390/cancers13153786
Chicago/Turabian Style
Bannaga, Ayman, Jochen Metzger, Torsten Voigtländer, Martin Pejchinovski, Maria Frantzi, Thorsten Book, Sean James, Kishore Gopalakrishnan, Harald Mischak, Michael P. Manns,
and et al. 2021. "Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma" Cancers 13, no. 15: 3786.
https://doi.org/10.3390/cancers13153786
APA Style
Bannaga, A., Metzger, J., Voigtländer, T., Pejchinovski, M., Frantzi, M., Book, T., James, S., Gopalakrishnan, K., Mischak, H., Manns, M. P., & Arasaradnam, R. P.
(2021). Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma. Cancers, 13(15), 3786.
https://doi.org/10.3390/cancers13153786